US Justice Department Nails Three In Mass Mailing Trademark Scam 20/07/2016 by Intellectual Property Watch Leave a Comment A Wells Fargo bank manager in California worked with two colleagues to conduct a scam targeting trademark holders and launder the proceeds, the United States Department of Justice said today.
TTIP Negotiators Need Many More Nights To Negotiate – And Are Planning Just That 15/07/2016 by Monika Ermert for Intellectual Property Watch 1 Comment Top negotiators of the European Union and United States today underlined after the 14th round of negotiations for the Transatlantic Trade and Investment Partnership (TTIP) that they are still on track for finalising the deal during the outgoing Obama administration. At the same time, they acknowledged that after three years of negotiations some chapters have never been discussed.
Orphan Drugs Finding Home In Markets: Could Be 20% Of All Sales By 2020 15/07/2016 by Intellectual Property Watch 2 Comments Worldwide sales for orphan drugs are forecast to reach $178 billion by 2020, according to a recent industry report. Moreover, the orphan drug market is expected to grow almost 12 percent per year, a level the broader pharmaceutical market “could only dream about” with its expected annual growth of 5.9 percent, according to Lisa Urquhart, editor of EvaluatePharma Vantage.
Gilead’s Use Of Patents For $10B Tax Dodge Could Ignite Move For Policy Change 13/07/2016 by William New, Intellectual Property Watch Leave a Comment Gilead is the US company whose use of patents to charge $1000 per pill for a hepatitis C medicine in the United States helped make high drug prices a developed country household issue and fodder for elected officials seeking change. Now the company has come under further fire after being found to have moved some US$10 billion overseas to avoid US taxes – even after having received US taxpayer support for its activities – which it orchestrated by moving its patent rights overseas. A new report detailing the company’s tax dodge includes a proposal for a way to clamp down on this type of patent activity.
How Are Licensors And Licensees Adapting To New Scenarios? 12/07/2016 by Magda Voltolini for Intellectual Property Watch Leave a Comment BARCELONA, Spain — A recent industry conference panel here covered topics of changing intellectual property scenarios perceived from different angles, in particular from operating companies which manufacture products or services and patent assertion entities (PAEs).
Focus On Medicines Patents & Prices Alone May Do More Harm Than Good 12/07/2016 by Intellectual Property Watch Leave a Comment Populism is in vogue these days and critics of pharmaceutical patents are trying to ride the wave, claiming that undermining patents will dramatically decrease prices but not reduce innovation. Both sides of that claim are flawed, writes Steven Tepp.
Privacy Shield May Not Be “Schrems-Proof”, But Passage Approved 11/07/2016 by Monika Ermert for Intellectual Property Watch Leave a Comment The European Commission is expected to pass a controversial declaration on the “adequacy of US data protection standards” on 12 July, making transfers of personal data from the European Union to the United States legal once more. [Update: Privacy Shield was announced today by the US and EU.]
CETA: Ripe For Provisional Implementation In January 2018? 10/07/2016 by Monika Ermert for Intellectual Property Watch 1 Comment The European Commission on 8 July published the finalized Comprehensive Economic Canada-EU Trade Agreement (CETA) and formally proposed to Council to sign the agreement, pushing for provisional implementation amidst ongoing discussions over competency issues with EU member states. After finalising CETA in August 2014, the controversial investor-state dispute settlement (ISDS) system was renegotiated last year.
US Industry Airs Hopes, Frustrations On IP Rights In India 05/07/2016 by Patralekha Chatterjee for Intellectual Property Watch Leave a Comment What do global innovators make of India’s new National Intellectual Property Rights Policy? A recent discussion on “India’s National IPR Strategy: A View from Global Innovators” in Washington DC attempted to assess the opportunities and challenges ahead from the perspective of American companies.
US Sees Weak African IP Protection, But Not Enough To Lose Unilateral Trade Benefits 30/06/2016 by William New, Intellectual Property Watch Leave a Comment The Office of the United States Trade Representative (USTR) today (29 June) released its annual report on the eligibility of African nations for unilateral trade benefits offered by the US. While some countries were praised for progress on intellectual property protection, others were found to be weak in this area, but none were removed from eligibility for that reason. Overall, reporting on IP rights varied widely in the report.